Related Experiment Video
Updated: Sep 21, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atrial septal defect and patent foramen ovale closure- complication profile of approved Gore Occluders
Michał Piotrowski1, Julia Izabela Karpierz2, Jakub Batko1
1CAROL-Cardiothoracic Anatomy Research Operative Lab, Department of Cardiovascular Surgery and Transplantology, Institute of Cardiology, Jagiellonian University Medical College, 31-008 Krakow, Poland.
Insights
This study analyzed Gore device complications for patent foramen ovale and atrial septal defects, finding device embolization and arrhythmias were common adverse events. No cardiac erosions were reported, but complication profiles varied by device and size.
Area of Science:
- Cardiovascular Medicine
- Medical Device Technology
- Congenital Heart Disease Research
Background:
- Patent foramen ovale and atrial septal defects are common congenital heart diseases requiring treatment.
- Percutaneous or surgical interventions are considered for symptomatic cases.
- Gore Cardioform and Gore Helex devices are used for closure procedures.
Purpose of the Study:
- To investigate the post-approval complication profiles of Gore Cardioform and Gore Helex devices.
- To analyze adverse events reported in the Manufacturer and User Facility Device Experience database.
Main Methods:
- A retrospective analysis of the Manufacturer and User Facility Device Experience Database.
- Inclusion of 401 reports detailing complications associated with Gore device closure of atrial septal defects.
- Categorization of reports by specific Gore device models (Cardioform Septal Occluder, Cardioform ASD Occluder, Helex Septal Occluder).
Main Results:
- Device problems accounted for 51.4% of complications, primarily device embolization (n=140).
- Three deaths were reported, two linked to device embolization.
- Other reported complications included pericardial effusion (54 cases), perforation (14 cases), and postoperative arrhythmias (80 cases), notably atrial fibrillation and heart block.
Conclusions:
- No cardiac erosions were identified with the use of Gore devices, aligning with previous findings.
- The complication profiles differed between the investigated Gore devices and their various sizes.
Background:
Patent foramen ovale and atrial septal defect are among the most common congenital heart diseases. When they are symptomatic, either pharmacologic or percutaneous/surgical treatment should be considered. The aim of this study was to investigate the post-approval complication profiles of the Gore Cardioform and Gore Helex devices based on the Manufacturer and User Facility Device Experience database.
Methods:
A search of the Manufacturer and User Facility Device Experience Database was performed to identify reports of complications following the closure of atrial septal defects with Gore devices. 401 reports met inclusion criteria, including 204 patients with Gore Cardioform Septal Occluder, 146 patients with Gore Cardioform ASD Occluder, and 51 patients with Gore Helex Septal Occluder.
Results:
The number of adverse events related to device problems contributed to 51.4 % of reported complications (n = 206), which mostly consisted of embolism of the device (n = 140). There were 3 reported cases of death, with 2 linked to device embolization. Most reports concerned devices sized 25 and 30 mm although only 313 reports (78.1 %) had information about size available. 54 cases of pericardial effusion and 14 cases of perforation were reported. Multiple postoperative arrhythmias were reported (n = 80), with the majority of them being atrial fibrillation (n = 39) or heart block (n = 18).
Conclusions:
No cardiac erosions linked to Gore devices were found throughout our analysis, supporting earlier literature findings. The investigated devices and their sizes varied in terms of complication profiles.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Aneurysm III: Interprofessional Care

